Patents by Inventor David O. Sullivan

David O. Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140197530
    Abstract: A semiconductor device is described having at least one semiconductor chip, the chip having an active area on a top side thereof, the active area formed at least in part of low-k material, said low-k material defining a low-k subarea of said active area; an embedding material, in which said at least one semiconductor chip is embedded, at least part of the embedding material forming a coplanar area with said active area; at least one contact area within the low-k subarea; a redistribution layer on the coplanar area, the redistribution layer connected to said contact areas; at least one first-level interconnect, located outside said low-k subarea, the first-level interconnect electrically connected to at least one of said contact areas via the redistribution layer.
    Type: Application
    Filed: January 11, 2013
    Publication date: July 17, 2014
    Applicant: Intel Mobile Communications GmbH
    Inventors: Thorsten Meyer, Sven Albers, Christian Geissler, Andreas Wolter, Markus Brunnbauer, David O'Sullivan, Frank Zudock, Jan Proschwitz
  • Patent number: 8709398
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: April 29, 2014
    Assignee: Alimentary Health Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Patent number: 8557233
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 15, 2013
    Assignee: Alimentary Heath Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Publication number: 20130190299
    Abstract: Methods and formulations for the treatment of multiple sclerosis with drugs with affinity for both serotonergic 5-HT2 and dopaminergic receptors such as the D2 receptor are herein disclosed. According to one embodiment, a method includes delivering a therapeutic dosage of drugs with affinity for both serotonergic 5-HT2 and dopaminergic receptors such as the D2 receptors to a subject exhibiting symptoms of multiple sclerosis to alleviate the symptoms.
    Type: Application
    Filed: June 28, 2011
    Publication date: July 25, 2013
    Applicant: Victoria Link Ltd.
    Inventors: Anne Camille La Flamme, Bronwen Jane Connor, David O'Sullivan
  • Publication number: 20130049205
    Abstract: A method of manufacturing a device includes providing a semiconductor chip having a first face and a second face opposite to the first face with a contact pad arranged on the first face. The semiconductor chip is placed on a carrier with the first face facing the carrier. The semiconductor chip is encapsulated with an encapsulation material. The carrier is removed and the semiconductor material is removed from the second face of the first semiconductor chip without removing encapsulation material at the same time.
    Type: Application
    Filed: August 25, 2011
    Publication date: February 28, 2013
    Applicant: Intel Mobile Communications GmbH
    Inventors: Thorsten Meyer, Klaus Reingruber, David O'Sullivan
  • Publication number: 20130023562
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 27, 2012
    Publication date: January 24, 2013
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Patent number: 8314127
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: November 20, 2012
    Assignee: Astrazeneca AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Publication number: 20120207713
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Application
    Filed: January 10, 2012
    Publication date: August 16, 2012
    Applicant: ALIMENTARY HEALTH LIMITED
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Publication number: 20110179451
    Abstract: Display features of an interactive user interface for a TV environment allow a user to interact with objects and/or information within a display space.
    Type: Application
    Filed: October 17, 2008
    Publication date: July 21, 2011
    Applicant: British Sky Broadcasting Ltd.
    Inventors: Marisa Miles, Gerry David O'Sullivan, Robin Crossley, Nicholas James
  • Publication number: 20110020284
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Application
    Filed: March 28, 2008
    Publication date: January 27, 2011
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Publication number: 20110020400
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Application
    Filed: March 28, 2008
    Publication date: January 27, 2011
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Patent number: 7846955
    Abstract: The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate, pharmaceutical compositions containing it, and its use in therapy.
    Type: Grant
    Filed: February 6, 2008
    Date of Patent: December 7, 2010
    Assignees: AstraZeneca AB, Argenta Discovery Ltd.
    Inventors: Barbara Giuseppina Avitabile, David O'Sullivan, Richard James Bull
  • Publication number: 20100093816
    Abstract: The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate, pharmaceutical compositions containing it, and its use in therapy.
    Type: Application
    Filed: February 6, 2008
    Publication date: April 15, 2010
    Applicants: ARGENTA DISCOVERY LTD., ASTRAZENECA AB
    Inventors: Barbara Giuseppina Avitabile, David O'Sullivan, James Richard Bull
  • Publication number: 20080207688
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Patent number: 4576402
    Abstract: A locking pipe sub is disclosed including a threaded pin connection for engaging, for example, a pipe stuck in a well bore. The threads on the pin are formed in two sections which are adapted to align upon initial make-up of the sub to the stuck pipe, but to misalign, both axially and radially, when reverse torque is applied to the sub. The result is to create axial and radial forces between the threads of the sub and the threads of the stuck pipe which positively lock the sub against disconnection from the pipe except with the use of a releasing tool.
    Type: Grant
    Filed: March 21, 1983
    Date of Patent: March 18, 1986
    Assignee: Tri-State Oil Tool Industries, Inc.
    Inventors: W. Kirby Murray, David O. Sullivan